Telestroke for Comprehensive Stroke Care in Acute Stroke Ready Hospitals
NCT03672890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 551
Last updated 2021-02-16
Summary
TELEstroke for Comprehensive Stroke Care in Acute Stroke Ready HospiTals (TELECAST) is a prospective single-center study evaluating guideline-based acute ischemic stroke care at an Acute Stroke Ready Hospital (ASRH) pre- and post-initiation of a specialist telestroke inpatient rounding service. TELECAST will study the following clinical endpoints: diagnostic stroke evaluation, secondary stroke prevention, health screening and evaluation, stroke education, inpatient complications, and stroke recurrence rates. Additional relevant non-clinical data will include patient and provider satisfaction scores, transfer patterns, and a cost analysis.
Conditions
Interventions
- OTHER
-
Telestroke
Telestroke is an audiovisual communication network that allows for coordination of stroke care from a distant 'hub' site (the telestroke provider location) to an originating 'spoke' site (patient location) in a HIPAA compliant fashion. In TELECAST, inpatient telestroke rounding will be used to oversee the urgent diagnostic stroke evaluation, secondary stroke prevention, health screening \& evaluation, and stroke education in patients admitted with stroke.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Christopher Streib, MD · University of Minnesota
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-02
- Primary Completion
- 2019-07-30
- Completion
- 2020-07-01
Countries
- United States
Study Locations
More Related Trials
-
Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
NCT05199194 ·Status: RECRUITING ·Phase: PHASE3
-
Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
NCT03785678 ·Status: COMPLETED ·Phase: PHASE3
-
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT06320431 ·Status: RECRUITING ·Phase: PHASE3
-
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
NCT02398656 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Intravenous Thrombolytics in Stroke on Awakening
NCT01643902 ·Status: COMPLETED ·Phase: PHASE2
-
Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients
NCT01586702 ·Status: COMPLETED ·Phase: NA
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
NCT05141305 ·Status: COMPLETED ·Phase: PHASE3
-
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
NCT03385928 ·Status: COMPLETED ·Phase: PHASE2
-
Assess the Penumbra System in the Treatment of Acute Stroke
NCT01429350 ·Status: COMPLETED ·Phase: PHASE4
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose
NCT06801054 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
NCT01098981 ·Status: TERMINATED ·Phase: PHASE3
-
Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
NCT02388061 ·Status: COMPLETED ·Phase: PHASE2
-
A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke
NCT06621121 ·Status: RECRUITING
-
The Norwegian Tenecteplase Stroke Trial 2
NCT03854500 ·Status: TERMINATED ·Phase: PHASE3
-
Tenecteplase in Wake-up Ischaemic Stroke Trial
NCT03181360 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke
NCT02039375 ·Status: COMPLETED ·Phase: NA
-
Argatroban Stroke Treatment - A Pilot Safety Study
NCT00268762 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stroke Telemedicine for Arizona Rural Residents Trial
NCT00829361 ·Status: COMPLETED ·Phase: NA
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3
-
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
NCT06010628 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety of Intravenous Thrombolysis for Wake-up Stroke
NCT01183533 ·Status: COMPLETED ·Phase: PHASE2